Particle.news
Type 2 Diabetes Medications Type 1 Diabetes Insulin Treatment Diabetes Medications Insulin Medical Conditions Clinical Trials Insulin Therapy Hypoglycemia Insulin Types Weight Loss Treatment Innovations GLP-1 Medications Complications Monitoring Treatment Options Screening Autoimmune Diseases Treatment Patient Education
The first nonpeptide oral GLP-1 therapy, orforglipron, matches injectable drugs in weight-loss and glucose-control efficacy, with FDA filings planned for late 2025.
